Research Protocol · Live
Vial · 10 mg
Research duration
Per vial
Cadence
DAILYPer dose
260 mcg
Per-administration dose
◀ DRAG TO SCRUB ▶
KPV 10mgResearch Peptide · PepC.Labs
Anti-inflammatory tripeptide derived from alpha-MSH (α-MSH 11-13). Studied for inhibition of NF-κB signalling in gut and immune research models.
Assayed Purity
99.00%
Method
HPLC
Certificate
Coming soon$6.50 / mg
In stock, ships from Sydney
For research use only. Not for human consumption. By purchasing this product, you confirm it will be used solely for legitimate research purposes.
Anti-inflammatory tripeptide derived from alpha-MSH (α-MSH 11-13). Studied for inhibition of NF-κB signalling in gut and immune research models.
KPV (Lysine-Proline-Valine) is a tripeptide fragment of alpha-melanocyte-stimulating hormone (α-MSH 11-13). Independent literature characterises KPV as a PepT1-mediated cellular signalling research tool. Once internalised, KPV is associated in published preclinical work with downregulation of NF-κB nuclear translocation, attenuated TNF-α, IL-1β, and IL-6 secretion under inflammatory challenge, and reduced disease activity scores in chemically induced colitis models. The compound has been investigated across oral, topical, transdermal, and rectal delivery routes in research animals. For research use only. Not for human consumption.
